In this context, PPAR-α agonists, such as PEA, may mediate TLR-4 down-regulation and efficiently suppress the inflammatory process similar to the evidence observed in vitro [15], clinical studies [34], endotoxin induced-uveitis rat model, and DSS-induced colitis mice model [21,35]. This evidence concerns the gene PPARA and colitis.